BACE1 SUMOylation deregulates phosphorylation and ubiquitination in Alzheimer's disease pathology

BACE1 is essential for the generation of amyloid‐β (Aβ) that likely initiates the toxicity in Alzheimer's disease (AD). BACE1 activity is mainly regulated by post‐translational modifications, but the relationship between these modifications is not fully characterized. Here, we studied the effects of BACE1 SUMOylation on its phosphorylation and ubiquitination. We demonstrate that SUMOylation of BACE1 inhibits its phosphorylation at S498 and its ubiquitination in vitro. Conversely, BACE1 phosphorylation at S498 suppresses its SUMOylation, which results in promoting BACE1 degradation in vitro. Furthermore, an increase in BACE1 SUMOylation is associated with the progression of AD pathology, while its phosphorylation and ubiquitination are decreased in an AD mouse model. Our findings suggest that BACE1 SUMOylation reciprocally influences its phosphorylation and competes against its ubiquitination, which might provide a new insight into the regulations of BACE1 activity and Aβ accumulation.

[1]  C. Montecucco,et al.  An agonist of CXCR4 induces a rapid recovery from the neurotoxic effects of Vipera ammodytes and Vipera aspis venoms , 2023, Journal of neurochemistry.

[2]  S. Kim,et al.  Hericerin derivatives activates a pan‐neurotrophic pathway in central hippocampal neurons converging to ERK1/2 signaling enhancing spatial memory , 2023, Journal of neurochemistry.

[3]  R. González-Prieto,et al.  Insights in Post-Translational Modifications: Ubiquitin and SUMO , 2022, International journal of molecular sciences.

[4]  B. de Strooper,et al.  The β-Secretase BACE1 in Alzheimer’s Disease , 2020, Biological Psychiatry.

[5]  O. Sporns,et al.  Brain Aβ load association and sexual dimorphism of plasma BACE1 concentrations in cognitively normal individuals at risk for AD , 2019, Alzheimer's & Dementia.

[6]  Nektarios Tavernarakis,et al.  SUMOylation in Neurodegenerative Diseases , 2019, Gerontology.

[7]  S. Chirumbolo,et al.  Molecular Targets in Alzheimer’s Disease , 2019, Molecular Neurobiology.

[8]  Bin Zhang,et al.  BACE1 SUMOylation increases its stability and escalates the protease activity in Alzheimer’s disease , 2018, Proceedings of the National Academy of Sciences.

[9]  Miao Sun,et al.  Par3 and aPKC regulate BACE1 endosome-to-TGN trafficking through PACS1 , 2017, Neurobiology of Aging.

[10]  G. Rammes,et al.  Beta-Site Amyloid Precursor Protein Cleaving Enzyme 1 Inhibition Impairs Synaptic Plasticity via Seizure Protein 6 , 2016, Biological Psychiatry.

[11]  J. Qian,et al.  SUMOylation of Rb enhances its binding with CDK2 and phosphorylation at early G1 phase , 2016, Cell cycle.

[12]  Stéphane Martin,et al.  Sumoylation in Synaptic Function and Dysfunction , 2016, Front. Synaptic Neurosci..

[13]  M. Altmeyer,et al.  Interplay between Ubiquitin, SUMO, and Poly(ADP-Ribose) in the Cellular Response to Genotoxic Stress , 2016, Front. Genet..

[14]  Xulun Zhang,et al.  The topology of pen-2, a γ-secretase subunit, revisited: evidence for a reentrant loop and a single pass transmembrane domain , 2015, Molecular Neurodegeneration.

[15]  K. Ye,et al.  SUMOylation at K340 inhibits tau degradation through deregulating its phosphorylation and ubiquitination , 2014, Proceedings of the National Academy of Sciences.

[16]  J. Henley,et al.  Neuronal SUMOylation: mechanisms, physiology, and roles in neuronal dysfunction. , 2014, Physiological reviews.

[17]  P. Wong,et al.  Function, therapeutic potential and cell biology of BACE proteases: current status and future prospects , 2014, Journal of neurochemistry.

[18]  F. Schmitt,et al.  Using mice to model Alzheimer's dementia: an overview of the clinical disease and the preclinical behavioral changes in 10 mouse models , 2014, Front. Genet..

[19]  G. Tesco,et al.  BACE1 Protein Endocytosis and Trafficking Are Differentially Regulated by Ubiquitination at Lysine 501 and the Di-leucine Motif in the Carboxyl Terminus* , 2012, The Journal of Biological Chemistry.

[20]  J. Mellor,et al.  SUMOylation and phosphorylation of GluK2 regulate kainate receptor trafficking and synaptic plasticity , 2012, Nature Neuroscience.

[21]  G. Tesco,et al.  Ubiquitin Regulates GGA3-mediated Degradation of BACE1* , 2010, The Journal of Biological Chemistry.

[22]  Yuan Chen,et al.  Phosphorylation-Dependent Interaction of SATB1 and PIAS1 Directs SUMO-Regulated Caspase Cleavage of SATB1 , 2010, Molecular and Cellular Biology.

[23]  Yong Shen,et al.  Alzheimer's disease-like pathological features in transgenic mice expressing the APP intracellular domain , 2009, Proceedings of the National Academy of Sciences.

[24]  E. J. Lee,et al.  Regulation of Glycogen Synthase Kinase 3β Functions by Modification of the Small Ubiquitin-Like Modifier , 2008, The open biochemistry journal.

[25]  P. Greengard,et al.  Regulation of Alzheimer's disease amyloid-β formation by casein kinase I , 2007, Proceedings of the National Academy of Sciences.

[26]  L. Sistonen,et al.  PDSM, a motif for phosphorylation-dependent SUMO modification. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[27]  R. Hay,et al.  SUMO: a history of modification. , 2005, Molecular cell.

[28]  Andrew D Sharrocks,et al.  Dynamic interplay of the SUMO and ERK pathways in regulating Elk-1 transcriptional activity. , 2003, Molecular cell.

[29]  A. Tomasselli,et al.  Employing a superior BACE1 cleavage sequence to probe cellular APP processing , 2003, Journal of neurochemistry.

[30]  A. Ciechanover,et al.  The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction. , 2002, Physiological reviews.

[31]  J. Buxbaum,et al.  The Carboxyl-Terminus of BACE Contains a Sorting Signal That Regulates BACE Trafficking but Not the Formation of Total Aβ , 2002, Molecular and Cellular Neuroscience.

[32]  R. Vassar.  The beta-secretase, BACE: a prime drug target for Alzheimer's disease. , 2001, Journal of molecular neuroscience : MN.

[33]  V. Katta,et al.  Characterization of Alzheimer's beta -secretase protein BACE. A pepsin family member with unusual properties. , 2000 .

[34]  Z. Ronai,et al.  SUMO-1 Modification of Mdm2 Prevents Its Self-Ubiquitination and Increases Mdm2 Ability to Ubiquitinate p53 , 2000, Cell.

[35]  D. Selkoe.  Alzheimer's disease. , 2011, Cold Spring Harbor perspectives in biology.

[36]  S. Miyamoto,et al.  Sequential modification of NEMO/IKKgamma by SUMO-1 and ubiquitin mediates NF-kappaB activation by genotoxic stress. , 2003, Cell.

[37]  Z. Ronai,et al.  SUMO-1 modification of Mdm2 prevents its self-ubiquitination and increases Mdm2 ability to ubiquitinate p53. , 2000, Cell.

[38]  Q. Wanga,et al.  BACE 1 SUMOylation increases its stability and escalates the protease activity in Alzheimer ' s disease , 2022 .